title: [2013 Guidelines ACC/AHA cardiovascular risk. Incomplete evidence and failed attempt at simplification].
abstract: After almost a decade, finally Guidelines for the management of hypercholesterolemia in adults by the AHA/ACC were published. The substantial change in the paradigm of this new recommendation is the treatment decision basically statin, based on a recalculation of cardiovascular risk. Four groups were identified and based on them different statins indication, according to the power applied. As is apparent, have been used only randomized clinical trials (RCT) as the sole basis for the drafting of these new guidelines. Two basic issues are reviewed and revised in the following article: leaving aside other types of evidence to generate the recommendation and on the other hand the attempt to simplify the interpretation and management of this condition. We stress the need for any recommendation to clinical reasoning to interpret different scenarios involved in each patient.
authors.affiliation: ICM (Instituto Clínica Médica), Mar del Plata, Argentina. Electronic address: drpablocorral@gmail.com.
authors.forename: Pablo
authors.initials: P
authors.lastname: Corral
mesh_terms: D000328:Adult; D000572:American Heart Association; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012955:Societies, Medical; D014481:United States
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Cardiovascular prevention guidelines; Cholesterol; Colesterol; Estatinas; Evidence; Evidencia; Guías prevención cardiovascular; Statins